APA

Dafflon C., Gaulis S., Barys L., Kapur K., Cornacchione V., Schukur L., Bergling S., Traggiai E., Jansky S., Hellmann L., Engstler B. S., Kerr G., de Weck A., Ruddy D. A., Naumann U., Stauffer F., Gaul C., Lin Y., Billy E., Weiss A., Hofmann F., Ito M. & Tiedt R. (2020). DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway. : Oncotarget.

Chicago

Dafflon Caroline, Gaulis Swann, Barys Louise, Kapur Karen, Cornacchione Vanessa, Schukur Lina, Bergling Sebastian, Traggiai Elisabetta, Jansky Selina, Hellmann Leon, Engstler Barbara Schacher, Kerr Grainne, de Weck Antoine, Ruddy David A, Naumann Ulrike, Stauffer Frédéric, Gaul Christoph, Lin Ying, Billy Eric, Weiss Andreas, Hofmann Francesco, Ito Moriko and Tiedt Ralph. 2020. DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway. : Oncotarget.

Harvard

Dafflon C., Gaulis S., Barys L., Kapur K., Cornacchione V., Schukur L., Bergling S., Traggiai E., Jansky S., Hellmann L., Engstler B. S., Kerr G., de Weck A., Ruddy D. A., Naumann U., Stauffer F., Gaul C., Lin Y., Billy E., Weiss A., Hofmann F., Ito M. and Tiedt R. (2020). DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway. : Oncotarget.

MLA

Dafflon Caroline, Gaulis Swann, Barys Louise, Kapur Karen, Cornacchione Vanessa, Schukur Lina, Bergling Sebastian, Traggiai Elisabetta, Jansky Selina, Hellmann Leon, Engstler Barbara Schacher, Kerr Grainne, de Weck Antoine, Ruddy David A, Naumann Ulrike, Stauffer Frédéric, Gaul Christoph, Lin Ying, Billy Eric, Weiss Andreas, Hofmann Francesco, Ito Moriko and Tiedt Ralph. DOT1L inhibition is lethal for multiple myeloma due to perturbation of the endoplasmic reticulum stress pathway. : Oncotarget. 2020.